HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 07-17-2008, 06:08 PM   #1
Jean
Senior Member
 
Join Date: Oct 2005
Location: New Jersey
Posts: 3,154
The Her2 Serum test is a biomarker test for tumor cells in the blood, it is rather new and many dr. are not using it. It does not inform you if herceptin is working for you. Rather it will show amount of her2 serum levels in the blood which would help you monitor your treatments.

Remember that during treatment you could be shedding dead cells into the blood and your levels may not indicate that herceptin is not working - maybe the chemo is not /so/a change in the chemo maybe the answer.

While we were out in S.D. we all had dinner with the
dr. who was the inventor of the test.

It is primarily for those who are in treatment for metastatic disease in order to check levels and to monitor if the treatment is working. It is important to have the test prior to treatment in order to achieve a base line.

Now, for those on cutting edge...this reminds me of the Oncotype DX test...in its early days, now being used by many onc. to determine if chemo should be used taking the guess work out of the equation, instead of using tumor size and node status, the Oncotype DX goes to the source, your very own gene makeup.

When I was speaking with the dr. he felt it would be a good idea to have a base line by having the test, my onc. in NJ does not use it for those with early stage.
I have not discussed it with Dr. Slamon/to ask if this is worth while. It is not invasive/so/if anyone is concerned it is just a blood test (I do not know the cost) but as Brenda mentions it is not written in stone yet and certainly not for early stagers, just yet. If anyone is interested I would be happy to contact the
dr. who invented the test and find out how much the cost is. I had planned on having the test as a baseline for myself. But my markers have been low as I go in for my 3 month checkups and I have felt satisfied.

Also, remember when having treatment in the early days and months of treatment the tumor cells are shedding and the level could be high so the test is
not ready for prime time just yet.

Ah, it seems we get one answer and then more quesions?

Hope this helps clear up any confusion.
I have posted a link.
http://diagnostics.siemens.com/webap...Id~e_10001.htm

Regards,
Jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006

Last edited by Jean; 07-17-2008 at 06:37 PM..
Jean is offline   Reply With Quote
Old 07-17-2008, 10:32 PM   #2
Janelle
Senior Member
 
Join Date: Nov 2007
Location: Brentwood, CA
Posts: 76
Excellent intelligence, Jean. I do not have mets but it makes sense for me to get a baseline now that I am finished with chemo and herceptin. It seems like this would be a logical way to show progression before other technologies pick up on something and diesease load increases. I would love any further info on the test (cost, etc) as I am determined to have this done.

Thank you so much for clarifying what the test was for and giving us the inside scoop. I am considering a vaccine trial for non-mets people. I think this would help me evaluate if the vaccine is working (assuming I don't get a placebo!).

Best,
Janelle
__________________
Janelle
Diagnosed October 2006 at age 37 wtih grade 3 IDC and high grade DCIS
Stage 1c triple positive, no node involvement but
vascular invasion
multifocal disease
Lumpectomy November, 2006
A/C every 3 weeks (started Jan., 2007 and finished March 2007); followed weekly Taxol (finished June 2007) concurrent with Herceptin (finished March 2008);
Bilateral Mast with immediate recon in Sept 2007; finished recon Dec. 2007
Started 5 years of tamoxifen Nov. 2007; started peptide vaccine clinical trial at MD Anderson October 2008 and finished active part of trial in April 2009 (monthly injections of AE37 peptitde (HLA type specific) with GM-CSF or GM-CSF alone depending on if I was in experimental or control group); started Zometa infusions June 25, 2009- 4mg every 6 months for 3 years (taking it "off-label" to try to prevent mets)
Janelle is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 04:24 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter